Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline
ConclusionCYP2B6 rs8109525 was associated with a higher success rate of smoking cessation with varenicline treatment. This finding may be useful in pharmacogenomic strategies for smoking cessation therapy.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Bupropion | Chantix | Drugs & Pharmacology | Genetics | Nicotine | Nicotine Replacement Therapy | Smokers | Study | Wellbutrin